[1]
Aktas, A. , Gunes, O., Olmez Budak, F., Diller, N., Tuncer, A. , Akbulut, S., Taskapan, M.C., Aydin, .C., Kayaalp, C. and Yilmaz, S. 2022. The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure. Annals of Medical Research. 29, 8 (Aug. 2022), 846–852.